It also proposes that Polygenic Risk Score (PRS) would be a useful tool in the future particularly in individuals with ATM P/LP variants to capture the risk associated with Single Nucleotide Polymorphisms (SNPs) and is likely to become increasingly important as individuals without a strong family history of cancer undergo genetic testing. Here, ATM is linked to cancer.